Tiospiron (Serbo-Croatian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Tiospiron" in Serbo-Croatian language version.

refsWebsite

Global rank Serbo-Croatian rank

14nih.gov

4^th place

3^rd place

11doi.org

2^nd place

3wikipedia.org

low place

2archive.org

6^th place

5^th place

2aspetjournals.org

6,663^rd place

1,410^th place

1sciencedirect.com

149^th place

32^nd place

1jcheminf.com

low place

33^rd place

1books.google.com

3^rd place

6^th place

1cambridge.org

305^th place

276^th place

archive.org

Borison RL, Sinha D, Haverstock S, McLarnon MC, Diamond BI (1989). „Efficacy and safety of tiospirone vs. haloperidol and thioridazine in a double-blind, placebo-controlled trial”. Psychopharmacology Bulletin 25 (2): 190–3. PMID 2574893.
Roth BL, Tandra S, Burgess LH, Sibley DR, Meltzer HY (August 1995). „D4 dopamine receptor binding affinity does not distinguish between typical and atypical antipsychotic drugs”. Psychopharmacology 120 (3): 365–8. DOI:10.1007/BF02311185. PMID 8524985.

aspetjournals.org

jpet.aspetjournals.org

Weiner DM, Burstein ES, Nash N, et al. (October 2001). „5-hydroxytryptamine2A receptor inverse agonists as antipsychotics”. The Journal of Pharmacology and Experimental Therapeutics 299 (1): 268–76. PMID 11561089.
Herrick-Davis K, Grinde E, Teitler M (October 2000). „Inverse agonist activity of atypical antipsychotic drugs at human 5-hydroxytryptamine2C receptors”. The Journal of Pharmacology and Experimental Therapeutics 295 (1): 226–32. PMID 10991983.

books.google.com

Nasrallah, Henry A.; Shriqui, Christian L (1995). Contemporary issues in the treatment of schizophrenia. Washington, DC: American Psychiatric Press. str. 313. ISBN 0-88048-681-3.

cambridge.org

journals.cambridge.org

Newman-Tancredi A, Assié MB, Leduc N, Ormière AM, Danty N, Cosi C (September 2005). „Novel antipsychotics activate recombinant human and native rat serotonin 5-HT1A receptors: affinity, efficacy and potential implications for treatment of schizophrenia”. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 8 (3): 341–56. DOI:10.1017/S1461145704005000. PMID 15707540.

doi.org

dx.doi.org

Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit
Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846. edit
Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594. edit
Yevich JP, New JS, Smith DW, et al. (March 1986). „Synthesis and biological evaluation of 1-(1,2-benzisothiazol-3-yl)- and (1,2-benzisoxazol-3-yl)piperazine derivatives as potential antipsychotic agents”. Journal of Medicinal Chemistry 29 (3): 359–69. DOI:10.1021/jm00153a010. PMID 2869146.
Jain AK, Kelwala S, Moore N, Gershon S (April 1987). „A controlled clinical trial of tiaspirone in schizophrenia”. International Clinical Psychopharmacology 2 (2): 129–33. DOI:10.1097/00004850-198704000-00006. PMID 2885367.
Ishizumi K, Kojima A, Antoku F, Saji I, Yoshigi M (December 1995). „Succinimide derivatives. II. Synthesis and antipsychotic activity of N-[4-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]butyl]-1,2-cis- cyclohexanedicarboximide (SM-9018) and related compounds”. Chemical & Pharmaceutical Bulletin 43 (12): 2139–51. DOI:10.1248/cpb.43.2139. PMID 8582016.
Sumiyoshi T, Suzuki K, Sakamoto H, et al. (February 1995). „Atypicality of several antipsychotics on the basis of in vivo dopamine-D2 and serotonin-5HT2 receptor occupancy”. Neuropsychopharmacology 12 (1): 57–64. DOI:10.1016/0893-133X(94)00064-7. PMID 7766287.
Roth BL, Tandra S, Burgess LH, Sibley DR, Meltzer HY (August 1995). „D4 dopamine receptor binding affinity does not distinguish between typical and atypical antipsychotic drugs”. Psychopharmacology 120 (3): 365–8. DOI:10.1007/BF02311185. PMID 8524985.
Rauly-Lestienne I, Boutet-Robinet E, Ailhaud MC, Newman-Tancredi A, Cussac D (October 2007). „Differential profile of typical, atypical and third generation antipsychotics at human 5-HT7a receptors coupled to adenylyl cyclase: detection of agonist and inverse agonist properties”. Naunyn-Schmiedeberg's Archives of Pharmacology 376 (1–2): 93–105. DOI:10.1007/s00210-007-0182-6. PMID 17786406.
Newman-Tancredi A, Assié MB, Leduc N, Ormière AM, Danty N, Cosi C (September 2005). „Novel antipsychotics activate recombinant human and native rat serotonin 5-HT1A receptors: affinity, efficacy and potential implications for treatment of schizophrenia”. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 8 (3): 341–56. DOI:10.1017/S1461145704005000. PMID 15707540.

jcheminf.com

Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846. edit

nih.gov

ncbi.nlm.nih.gov

Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit
Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846. edit
Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594. edit
Yevich JP, New JS, Smith DW, et al. (March 1986). „Synthesis and biological evaluation of 1-(1,2-benzisothiazol-3-yl)- and (1,2-benzisoxazol-3-yl)piperazine derivatives as potential antipsychotic agents”. Journal of Medicinal Chemistry 29 (3): 359–69. DOI:10.1021/jm00153a010. PMID 2869146.
Jain AK, Kelwala S, Moore N, Gershon S (April 1987). „A controlled clinical trial of tiaspirone in schizophrenia”. International Clinical Psychopharmacology 2 (2): 129–33. DOI:10.1097/00004850-198704000-00006. PMID 2885367.
Moore NC, Meyendorff E, Yeragani V, LeWitt PA, Gershon S (April 1987). „Tiaspirone in schizophrenia”. Journal of Clinical Psychopharmacology 7 (2): 98–101. PMID 3294920.
Borison RL, Sinha D, Haverstock S, McLarnon MC, Diamond BI (1989). „Efficacy and safety of tiospirone vs. haloperidol and thioridazine in a double-blind, placebo-controlled trial”. Psychopharmacology Bulletin 25 (2): 190–3. PMID 2574893.
Ishizumi K, Kojima A, Antoku F, Saji I, Yoshigi M (December 1995). „Succinimide derivatives. II. Synthesis and antipsychotic activity of N-[4-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]butyl]-1,2-cis- cyclohexanedicarboximide (SM-9018) and related compounds”. Chemical & Pharmaceutical Bulletin 43 (12): 2139–51. DOI:10.1248/cpb.43.2139. PMID 8582016.
Sumiyoshi T, Suzuki K, Sakamoto H, et al. (February 1995). „Atypicality of several antipsychotics on the basis of in vivo dopamine-D2 and serotonin-5HT2 receptor occupancy”. Neuropsychopharmacology 12 (1): 57–64. DOI:10.1016/0893-133X(94)00064-7. PMID 7766287.
Roth BL, Tandra S, Burgess LH, Sibley DR, Meltzer HY (August 1995). „D4 dopamine receptor binding affinity does not distinguish between typical and atypical antipsychotic drugs”. Psychopharmacology 120 (3): 365–8. DOI:10.1007/BF02311185. PMID 8524985.
Weiner DM, Burstein ES, Nash N, et al. (October 2001). „5-hydroxytryptamine2A receptor inverse agonists as antipsychotics”. The Journal of Pharmacology and Experimental Therapeutics 299 (1): 268–76. PMID 11561089.
Herrick-Davis K, Grinde E, Teitler M (October 2000). „Inverse agonist activity of atypical antipsychotic drugs at human 5-hydroxytryptamine2C receptors”. The Journal of Pharmacology and Experimental Therapeutics 295 (1): 226–32. PMID 10991983.
Rauly-Lestienne I, Boutet-Robinet E, Ailhaud MC, Newman-Tancredi A, Cussac D (October 2007). „Differential profile of typical, atypical and third generation antipsychotics at human 5-HT7a receptors coupled to adenylyl cyclase: detection of agonist and inverse agonist properties”. Naunyn-Schmiedeberg's Archives of Pharmacology 376 (1–2): 93–105. DOI:10.1007/s00210-007-0182-6. PMID 17786406.
Newman-Tancredi A, Assié MB, Leduc N, Ormière AM, Danty N, Cosi C (September 2005). „Novel antipsychotics activate recombinant human and native rat serotonin 5-HT1A receptors: affinity, efficacy and potential implications for treatment of schizophrenia”. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 8 (3): 341–56. DOI:10.1017/S1461145704005000. PMID 15707540.

sciencedirect.com

Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit

wikipedia.org

sh.wikipedia.org

Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit
Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846. edit
Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594. edit